Literature DB >> 1452355

Organization of aerobactin, hemolysin, and antibacterial resistance genes in lactose-negative Escherichia coli strains of serotype O4 isolated from children with diarrhea.

B Colonna1, L Ranucci, P A Fradiani, M Casalino, A Calconi, M Nicoletti.   

Abstract

Epidemiologically related, non-lactose-fermenting (NLF) Escherichia coli strains of serotype O4 have been isolated at a high frequency from children with diarrhea in Somalia (M. Nicoletti, F. Superti, C. Conti, A. Calconi, and C. Zagaglia, J. Clin. Microbiol. 26:524-529, 1988). In order to define the virulence potential of these strains, we characterized the replication properties of their high-molecular-weight plasmids and studied the genetic locations and organization of the aerobactin (aer) and hemolysin (hly) determinants encoded by 23 NLF O4 E. coli strains. Southern blot hybridizations, mobilization assays of nonconjugative plasmids, and incompatibility-exclusion experiments conducted with a conjugative incompatibility group FI (IncFI) plasmid showed that (i) 20 out of the 23 strains examined harbor a 160- to 180-kb IncFI plasmid that shares homology with the basic replicons RepFIA, RepFIB, and (except for the plasmid of one strain) RepFIC, and 22 strains also contain a 40- to 140-kb IncFII plasmid sharing homology with the RepFIIA replicon; (ii) the IncFI plasmid is nonconjugative and carries antibiotic resistance genes; (iii) the aer system is located on the IncFI plasmids and/or the chromosomes in the three strains not harboring IncFI, and it is found in an inverted orientation; (iv) the hly determinants are located on the chromosome, and their genetic organization is well conserved and closely resembles that of the reference hemolytic plasmid pHly152; and (v) Hly- mutants obtained by transposon insertion mutagenesis are not cytotoxic to HeLa cell monolayers, indicating that hemolysin is responsible for the high cytotoxic activity we have previously reported for these strains. The structural organization of the plasmid-encoded aer operon, together with the finding that those plasmids also carry antibiotic resistance genes, indicates that the IncFI plasmid of the NLF O4 E. coli strains studied more closely resembles aer-encoding virulence IncFI Salmonella R plasmids than E. coli ColV plasmids. The data presented here cannot rule out whether the strains examined are potentially intestinal or extraintestinal pathogens. Nevertheless, the genetic organization of the virulence genes, together with the epidemiological behavior and the wide spectrum of antibiotic resistance of the NLF O4 E. coli strains, indicates that these strains are structured as typical E. coli pathogenic isolates of human origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452355      PMCID: PMC258301          DOI: 10.1128/iai.60.12.5224-5231.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A series of Tn5 variants with various drug-resistance markers and suicide vector for transposon mutagenesis.

Authors:  C Sasakawa; M Yoshikawa
Journal:  Gene       Date:  1987       Impact factor: 3.688

2.  Influence of cloned Escherichia coli hemolysin genes, S-fimbriae and serum resistance on pathogenicity in different animal models.

Authors:  J Hacker; H Hof; L Emödy; W Goebel
Journal:  Microb Pathog       Date:  1986-12       Impact factor: 3.738

Review 3.  Identification and classification of bacterial plasmids.

Authors:  M Couturier; F Bex; P L Bergquist; W K Maas
Journal:  Microbiol Rev       Date:  1988-09

4.  A two-year study of enteric infections associated with diarrhoeal diseases in children in urban Somalia.

Authors:  M Casalino; M W Yusuf; M Nicoletti; P Bazzicalupo; A Coppo; B Colonna; C Cappelli; C Bianchini; V Falbo; H J Ahmed
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

5.  Distribution of basic replicons having homology with RepFIA, RepFIB, and RepFIC among IncF group plasmids.

Authors:  P L Bergquist; S Saadi; W K Maas
Journal:  Plasmid       Date:  1986-01       Impact factor: 3.466

6.  Nucleotide sequence analysis of RepFIC, a basic replicon present in IncFI plasmids P307 and F, and its relation to the RepA replicon of IncFII plasmids.

Authors:  S Saadi; W K Maas; D F Hill; P L Bergquist
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

7.  Occurrence of chromosome- or plasmid-mediated aerobactin iron transport systems and hemolysin production among clonal groups of human invasive strains of Escherichia coli K1.

Authors:  M A Valvano; R P Silver; J H Crosa
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections.

Authors:  N H Carbonetti; S Boonchai; S H Parry; V Väisänen-Rhen; T K Korhonen; P H Williams
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

Review 9.  Colicin V virulence plasmids.

Authors:  V L Waters; J H Crosa
Journal:  Microbiol Rev       Date:  1991-09

10.  Virulence plasmids of enteroinvasive Escherichia coli and Shigella flexneri integrate into a specific site on the host chromosome: integration greatly reduces expression of plasmid-carried virulence genes.

Authors:  C Zagaglia; M Casalino; B Colonna; C Conti; A Calconi; M Nicoletti
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  12 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Plasmid-borne virulence-associated genes have a conserved organization in virulent strains of avian pathogenic Escherichia coli.

Authors:  Kelly A Tivendale; Joanne L Allen; Glenn F Browning
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

3.  Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea.

Authors:  S J Elliott; S Srinivas; M J Albert; K Alam; R M Robins-Browne; S T Gunzburg; B J Mee; B J Chang
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Murine monoclonal antibodies against Escherichia coli O4 lipopolysaccharide and H5 flagellin.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Detection of Escherichia coli, Salmonella spp., Shigella spp., Yersinia enterocolitica, Vibrio cholerae, and Campylobacter spp. enteropathogens by 3-reaction multiplex polymerase chain reaction.

Authors:  Oscar G Gómez-Duarte; Jing Bai; Elizabeth Newell
Journal:  Diagn Microbiol Infect Dis       Date:  2008-11-06       Impact factor: 2.803

6.  Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves.

Authors:  Artashes R Khachatryan; Dale D Hancock; Thomas E Besser; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

7.  Characterization of endemic Shigella flexneri strains in Somalia: antimicrobial resistance, plasmid profiles, and serotype correlation.

Authors:  M Casalino; M Nicoletti; A Salvia; B Colonna; C Pazzani; A Calconi; K A Mohamud; F Maimone
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Escherichia coli strains involved in diarrhea in France: high prevalence and heterogeneity of diffusely adhering strains.

Authors:  C Jallat; V Livrelli; A Darfeuille-Michaud; C Rich; B Joly
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Association between alpha-hemolysin production and HeLa cell-detaching activity in fecal isolates of Escherichia coli.

Authors:  L R Marques; C M Abe; P M Griffin; T A Gomes
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Clonal relationships among bloodstream isolates of Escherichia coli.

Authors:  J N Maslow; T S Whittam; C F Gilks; R A Wilson; M E Mulligan; K S Adams; R D Arbeit
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.